GTx-104 is designed for IV infusion in aSAH patients to address unmet medical needs and potentially simplify administration in the ICU, especially for unconscious or dysphagic patients.

The injectable formulation of nimodipine is in clinical stages, being developed for IV infusions in patients ... III STRIVE-ON safety clinical trial of GTx-104 met its primary endpoint and ...